Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Short term Debt (2020 - 2023)

Alx Oncology Holdings' Short term Debt history spans 4 years, with the latest figure at $830000.0 for Q1 2023.

  • For Q1 2023, Short term Debt changed N/A year-over-year to $830000.0; the TTM value through Mar 2023 reached $830000.0, changed N/A, while the annual FY2022 figure was $1.6 million, 1.23% up from the prior year.
  • Short term Debt for Q1 2023 was $830000.0 at Alx Oncology Holdings, down from $1.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $2.8 million in Q3 2022 and bottomed at $830000.0 in Q1 2023.
  • The 4-year median for Short term Debt is $1.7 million (2020), against an average of $2.0 million.
  • The largest YoY upside for Short term Debt was 1.23% in 2022 against a maximum downside of 1.23% in 2022.
  • A 4-year view of Short term Debt shows it stood at $2.6 million in 2020, then tumbled by 36.6% to $1.6 million in 2021, then increased by 1.23% to $1.6 million in 2022, then tumbled by 49.7% to $830000.0 in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Short term Debt are $830000.0 (Q1 2023), $1.6 million (Q4 2022), and $2.8 million (Q3 2022).